Digital Intervention for Loneliness in Aging Adults
(Dynamo Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a digital meditation app to assess its impact on the emotional well-being of older adults experiencing loneliness. Researchers aim to understand how meditation might alter brain activity and stress responses, using tools like EEG and fMRI (types of brain scans). Participants will use the app daily for six weeks, with some starting after a waitlist period. The trial seeks individuals aged 60 or older who do not currently meditate regularly and have no major cognitive issues, such as dementia.
As an unphased trial, this study offers participants the chance to contribute to groundbreaking research on meditation and emotional well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this digital meditation intervention is safe for aging adults?
Research shows that digital meditation apps are generally safe for users. Studies have found that these apps can reduce feelings of loneliness and improve social interactions without causing significant side effects. One study of a similar meditation app on smartphones reported benefits such as reduced burnout and did not find any major negative effects.
As a digital tool, it poses no physical risks like those associated with medication. The focus on mindfulness and meditation is something most people handle well. Overall, many have used digital meditation apps successfully without serious safety issues.12345Why are researchers excited about this trial?
Researchers are excited about the digital meditation app for addressing loneliness in aging adults because it offers a novel, accessible approach compared to traditional methods like therapy or medication. Unlike other treatments that might require face-to-face interaction or regular prescription use, this intervention leverages technology, allowing individuals to engage with it conveniently from home. Additionally, by using meditation to potentially affect brain function, it aims to address loneliness on a physiological level, which is a unique mechanism not typically targeted by standard care options. This trial could reveal new insights into how digital interventions can effectively mitigate loneliness, providing a scalable solution that can reach a wide audience.
What evidence suggests that this trial's digital meditation intervention could be effective for loneliness in aging adults?
This trial will evaluate a digital meditation program designed to reduce loneliness in aging adults. Research has shown that mindfulness training, included in the digital meditation program for this trial, can reduce feelings of loneliness by 22% and enhance social connections. Studies have also found that mindfulness and positive thinking exercises can improve mood and mental sharpness in older adults. A recent study showed that a smartphone-based mindfulness program helped people feel less lonely and increased their social interactions. Additionally, meditation apps, which are very popular, have been found to slightly reduce depression and anxiety. Overall, digital meditation appears promising for improving emotional health in lonely older adults.12567
Who Is on the Research Team?
Lorenzo Pasquini, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for English-speaking older adults who are 65 or above, have little to no experience with meditation, and are cognitively healthy without major systemic diseases. They must not be active meditators, taking psychotropic drugs, or have severe psychiatric conditions. Also excluded are those with MRI contraindications like metal implants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with the digital meditation app for 15 minutes a day, five days a week for 6 weeks
Waitlist Control
Participants in the waitlist control group do not receive the intervention for the first 6 weeks
Follow-up
Participants are monitored for changes in emotional well-being, loneliness, anxiety, stress, and depression after completing the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Active placebo
- Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute on Aging (NIA)
Collaborator